ABBOTT LABORATORIES — Director's Dealing 2016

Jul 27, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2016-07-25

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-25	Common shares without par value	P	233	$43.3025	Acquired	2724317	Direct
2016-07-25	Common shares without par value	P	300	$43.28	Acquired	2724617	Direct
2016-07-25	Common shares without par value	P	900	$43.315	Acquired	2725517	Direct
2016-07-25	Common shares without par value	P	500	$43.38	Acquired	2726017	Direct
2016-07-25	Common shares without par value	P	4800	$43.365	Acquired	2730817	Direct
2016-07-25	Common shares without par value	P	2000	$43.35	Acquired	2732817	Direct
2016-07-25	Common shares without par value	P	3000	$43.345	Acquired	2735817	Direct
2016-07-25	Common shares without par value	P	100	$43.3325	Acquired	2735917	Direct
2016-07-25	Common shares without par value	P	600	$43.385	Acquired	2736517	Direct
2016-07-25	Common shares without par value	P	5300	$43.30	Acquired	2741817	Direct
2016-07-25	Common shares without par value	P	200	$43.37	Acquired	2742017	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	29728	Indirect
Common shares without par value	8818	Indirect
Common shares without par value	8832	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of July 25, 2016.

F2: The reporting person disclaims beneficial ownership of all securities held by his son.